IRIS
INDIVERI, CESARE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 631
EU - Europa 143
AS - Asia 80
SA - Sud America 1
Totale 855
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 624
IT - Italia 57
SE - Svezia 45
SG - Singapore 40
CN - Cina 30
DE - Germania 10
FR - Francia 10
IN - India 8
CA - Canada 7
GB - Regno Unito 7
BE - Belgio 6
FI - Finlandia 3
IE - Irlanda 3
AE - Emirati Arabi Uniti 1
AR - Argentina 1
MD - Moldavia 1
RU - Federazione Russa 1
UZ - Uzbekistan 1
Totale 855
Salva come PNG Salva come JPEG
Città #
Chandler 109
Fairfield 71
Ashburn 50
Nyköping 42
Woodbridge 42
Seattle 39
Ann Arbor 35
Singapore 34
Houston 28
Wilmington 28
Grottaglie 23
Cambridge 17
Bari 15
Lawrence 14
Inglewood 10
New York 8
Pune 8
Roxbury 8
Beijing 7
Calgary 7
Brussels 6
Des Moines 6
Dearborn 5
Nanjing 5
Los Angeles 4
Boardman 3
Dublin 3
Hefei 3
Nanchang 3
Berlin 2
Bisceglie 2
Cerignola 2
Croydon 2
Guangzhou 2
Paris 2
Princeton 2
San Diego 2
Santa Clara 2
Shenyang 2
Auburn Hills 1
Bitonto 1
Brescia 1
Buenos Aires 1
Edinburgh 1
Falkenstein 1
Frankfurt am Main 1
Grafing 1
Helsinki 1
Jiaxing 1
Jinan 1
Kunming 1
Manchester 1
Mascalucia 1
Munich 1
Redwood City 1
Tappahannock 1
Tashkent 1
Torre Del Greco 1
Wenzhou 1
Totale 673
Salva come PNG Salva come JPEG
Nome #
Inactivation of the glutamine/amino acid transporter ASCT2 by 1,2,3-dithiazoles: Proteoliposomes as a tool to gain insights in the molecular mechanism of action and of antitumor activity 110
null 94
MODULATING CELLULAR FLAVIN COFACTOR LEVELS IN HUMANS VIA THE BI-FUNCTIONAL AND MONOFUNCTIONAL FLAD1 GENE PRODUCTS 92
null 57
null 50
Mimicking human riboflavin responsive neuromuscular disorders by silencing flad-1 gene in C. elegans: Alteration of vitamin transport and cholinergic transmission 46
Tryptophan 224 of the rat mitochondrial carnitine/acylcarnitine carrier is crucial for the antiport mechanism 44
null 43
Functional Study of the Human Riboflavin Transporter 2 Using Proteoliposomes System 35
hFADS6 and its “supermutant”: a possible therapeutic target? 30
FAD forming and destroying via human FAD synthase: a puzzle of modulated and modulating activities 30
Impact of natural mutations on the riboflavin transporter 2 and their relevance to human riboflavin transporter deficiency 2 30
Mutation of aspartate 238 in FAD synthase isoform 6 increases the specific activity by weakening the FAD binding 28
The hidden side of the human FAD synthase 2 25
Over-expression in Escherichia coli and purification of a novel isoform of human FAD synthase. 24
Over-expression, purification and functional characterization of a novel isoform of human FAD synthase. 23
E6 and E7 from human papillomavirus type 16 cooperate to target the PDZ protein Na/H exchange regulatory factor-1 23
Structure/function relationships of the human mitochondrial ornithine/citrulline carrier by Cys site-directed mutagenesis. Relevance to mercury toxicity 22
Functional characterization and homology modeling of a novel monofunctional isoform of human FAD synthase. 22
In silico investigation on structure-function relationship of members belonging to the human SLC52 transporter family 17
Proline/Glycine residues of the PG-levels guide conformational changes along the transport cycle in the mitochondrial carnitine/acylcarnitine carrier (SLC25A20) 14
Increased demand for FAD synthesis in differentiated and stem pancreatic cancer cells is accomplished by modulating FLAD1 gene expression: the inhibitory effect of Chicago Sky Blue 12
The Mycotoxin Patulin Inhibits the Mitochondrial Carnitine/Acylcarnitine Carrier (SLC25A20) by Interaction with Cys136 Implications for Human Health 11
Structural insights into the bifunctional enzyme human FAD synthase 9
Totale 891
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.149
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.149
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020142 0 0 0 0 22 15 23 25 26 16 9 6
2020/202190 6 8 11 3 11 16 5 5 6 9 4 6
2021/202274 5 5 1 1 6 4 4 3 5 5 15 20
2022/2023250 16 37 18 16 27 36 3 35 47 2 12 1
2023/2024100 7 18 4 26 3 19 10 2 0 3 3 5
2024/2025112 12 4 23 43 30 0 0 0 0 0 0 0
Totale 891